Connection
Mary Sammel to Disease-Free Survival
This is a "connection" page, showing publications Mary Sammel has written about Disease-Free Survival.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.036 |
|
|
|
-
Adams SF, Marsh EB, Elmasri W, Halberstadt S, Vandecker S, Sammel MD, Bradbury AR, Daly M, Karlan B, Rubin SC. A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer. Gynecol Oncol. 2011 Dec; 123(3):486-91.
Score: 0.019
-
Huang JH, Lee FS, Pasha TL, Sammel MD, Karakousis G, Xu G, Fraker D, Zhang PJ. Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications. Cancer Biol Ther. 2010 Feb; 9(4):303-11.
Score: 0.017